48 Results for "

LXRα

" in MedChemExpress (MCE) Product Catalog:
Products (48)

48 Results for "LXRα" in MCE Product Catalog:

49
49 Publications Verification
Cat. No.: HY-10626
CAS No.: 293754-55-9
Purity:  99.93%
T0901317 is an orally active and highly selective LXR agonist with an EC50 of 20 nM for LXRα . T0901317 activates FXR with an EC50 of 5 μM . T0901317 is RORα and RORγ dual inverse agonist with Ki values of 132 nM and 51 nM, respectively . T0901317 induces apoptosis and inhibits the development of atherosclerosis in low-density lipoprotein (LDL) receptor-deficient mice .
loading...
    loading...
37
37 Cited Publications
Cat. No.: HY-108688
CAS No.: 1221277-90-2
Purity:  99.37%
Target:  

LXR

Research Areas:  

Metabolic Disease

GSK2033 is a LXR antagonist with pIC50s of 7 and 7.4 for LXRα or LXRβ, respectively.
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-10629
CAS No.: 875787-07-8
Purity:  99.95%
Synonyms: WAY 252623
Target:  

LXR

Research Areas:  

Metabolic Disease Cancer

LXR-623 is a brain-penetrant partial LXRα and full LXRβ agonist, with IC50s of 24 nM and 179 nM, respectively.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-N1178
CAS No.: 1059-14-9
Taraxasterol is a pentacyclic triterpenoid compound isolated from Taraxacum mongolicum. Taraxasterol is an LXRα activator, with metabolic and anti-inflammatory effects. Taraxasterol may be used in research on immune-inflammatory diseases .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-112813
CAS No.: 2247372-59-2
Purity:  99.42%
Research Areas:  

Metabolic Disease

TUG-1375 is an agonist of free fatty acid receptor 2 (FFA2/GPR43), with a pKi of 6.69. TUG-1375 is inactive on FFA3, FFA4, PPARα, PPARγ, PPARδ, LXRα or LXRβ .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-101442
CAS No.: 1416153-62-2
Purity:  99.89%
Target:  

LXR

Research Areas:  

Metabolic Disease

SR9238 is a synthetic liver X receptor (LXR) inverse agonist with IC50s of 214 nM and 43 nM for LXRα and LXRβ, respectively.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N1970
CAS No.: 31721-94-5
5,7-Dihydroxychromone is a flavonoid compound with antioxidant properties. 5,7-Dihydroxychromone induces Nrf2 nuclear translocation, increases Nrf2/ARE binding activity, and up-regulates Nrf2-dependent antioxidant genes HO-1, NQO1, GCLc. 5,7-Dihydroxychromone attenuates excessive ROS generation, inhibits activated caspase-3, caspase-9, cleaved PARP expression, and prevents neuronal apoptosis and cell death. 5,7-Dihydroxychromone increases LXRα and PPARγ mRNA expression, induces preadipocyte differentiation, and regulates blood glucose levels. 5,7-Dihydroxychromone inhibits radial growth of soil pathogenic fungi, radicle elongation of select seedlings, and transiently inhibits Bradyrhizobium sp. growth in high mannitol medium. 5,7-Dihydroxychromone can be used for the research of Parkinson’s disease, type 2 diabetes mellitus and pathogenic fungal infection .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N0835
CAS No.: 34080-08-5
Synonyms: 20(S)-APPT; g-PPT
(20S)-Protopanaxatriol is a metabolite of ginsenoside. (20S)-Protopanaxatriol works through the glucocorticoid receptor (GR) and estrogen receptor (ER), and is also a LXRα inhibitor. (20S)-Protopanaxatriol shows a broad spectrum of antitumor effects .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19919
CAS No.: 918348-67-1
Synonyms: EXEL04286652; XL-652; BMS-788
Target:  

LXR

Research Areas:  

Metabolic Disease

BMS-779788 is a LXR partial agonist with IC50 values of 68 nM for LXRα and 14 nM for LXRβ.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-18282
CAS No.: 898800-26-5
Target:  

LXR

AZ876 is a selective, orally active agonist of liver X receptor (LXRα/β) (Ki=0.007 μM [LXRα, human], 0.011 μM [LXRβ, human]. AZ876 induces the expression of target genes such as ABCA1 and ABCG1, promotes reverse cholesterol transport (RCT) and regulates lipid metabolism and anti-inflammatory effects. AZ876 increases cardiac polyunsaturated fatty acid levels, reduces myocardial fibrosis, and reduces lesion area and monocyte adhesion in atherosclerosis models. AZ876 can be used in cardiovascular disease research, such as preventing and treating β-adrenergic-induced cardiac diastolic dysfunction and inhibiting the progression of atherosclerosis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-117006
CAS No.: 1031195-19-3
Purity:  98.55%
Synonyms: 1-{4-[2-(5-Methylfuran-2-yl)quinoline-4-carbonyl]piperazin-1-yl}ethan-1-one
Target:  

Sirtuin

Research Areas:  

Cardiovascular Disease

E1231 is an orally active activator of Sirtuin 1 (SIRT1) (EC50=0.83 μM), to modulate cholesterol and lipid metabolism. E1231 interactes with SIRT1 (KD=9.61 μM) and deacetylated liver X receptor-alpha (LXRα), and increases ATP-binding cassette transporter A1 (ABCA1) expression. E1231 also reduces atherosclerotic plaque development in ApoE -/- mice model. E1231 can be used for research in cholesterol and lipid disorder-related diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P87801
Synonyms: LXRA, NR1H3, Oxysterols receptor LXR-alpha, Liver X receptor alpha, Nuclear receptor subfamily 1 group H member 3

Host:  

Rabbit

Application:  

WB, ICC/IF, ELISA

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-128671
CAS No.: 574-25-4
Purity:  98.08%
Synonyms: 6TI; 6-Mercaptopurine riboside
Target:  

PPAR LXR JNK NO Synthase

Research Areas:  

Metabolic Disease

6-Thioinosine (6TI) is a purine antimetabolite and an anti-adipogenic agent. 6-Thioinosine reduces the mRNA levels of PPARγ and C/EBPα and downregulates the mRNA levels of PPARγ target genes (LPL, CD36, aP2, and LXRα). 6-Thioinosine exerts its anti-adipogenic effects by downregulating PPARγ through JNK-dependent iNOS upregulation. 6-Thioinosine can be used to study adipocyte dysfunction .
loading...
    loading...
Cat. No.: HY-144549
CAS No.: 1779524-90-1
Purity:  99.95%
Target:  

LXR

Research Areas:  

Cardiovascular Disease

LXR (Liver X receptor) agonist 1 is potent LXR agonist with AC50s of 1.5 nM and 12 nM for LXR-α and LXR-β, respectively. LXR agonist 1 has the potential for the research of atherosclerosis .
loading...
    loading...
Cat. No.: HY-123148
CAS No.: 870768-70-0
Purity:  99.85%
Target:  

LXR

Research Areas:  

Inflammation/Immunology

IMB-808 is a potent LXRα/β dual agonist with EC50 values of 0.53 μM and 0.15 μM (0.15 μM, using GAL4-pGL4-luc reporter plasmid) for LXRβ and LXRα, respectively. IMB-808 promotes expression of genes related to reverse cholesterol transport (ABCA1 and ABCG1). IMB-808 can be used for the study of atherosclerosis research .
loading...
    loading...
Cat. No.: HY-117549
CAS No.: 133208-93-2
Purity:  99.48%
Synonyms: NO-1886
Target:  

Lipase

Research Areas:  

Cardiovascular Disease

Ibrolipim (NO-1886) is an orally active lipoprotein lipase (LPL)-promoting agent. Ibrolipim decreases plasma triglycerides, increases high-density lipoprotein cholesterol levels. Ibrolipim has renoprotective and hypolipidemic effects .
loading...
    loading...
Cat. No.: HY-N2509
CAS No.: 86849-77-6
Synonyms: Iristectrigenin B
Iristectorigenin B (Iristectrigenin B) is a liver X receptor (LXR) modulator. Iristectrigenin B stimulates the transcriptional activity of both LXR-α and LXR-β .
loading...
    loading...
Cat. No.: HY-116969
CAS No.: 17954-98-2
Purity:  ≥98.0%
Synonyms: Narthesterol
22 (R)-Hydroxycholesterol (Narthesterol) is a natural oxysterol, acting as a LXRα agonist that inhibits cancer cell proliferation. 22 (R)-Hydroxycholesterol activates LXRα-mediated upregulation of downstream ABCA1 expression, enhances apolipoprotein-dependent cholesterol efflux, reduces intracellular cholesterol content, and decreases the production of β-amyloid peptide. 22 (R)-Hydroxycholesterol induces the differentiation of human mesenchymal stem cells into functional dopaminergic neurons. 22 (R)-Hydroxycholesterol is applicable to research related to cancer, Alzheimer's disease, and Parkinson's disease .
loading...
    loading...
Cat. No.: HY-W587772
CAS No.: 1684398-38-6
Synonyms: MEHHTP
Target:  

Drug Metabolite

Research Areas:  

Metabolic Disease

Mono (2-ethyl-5-hydroxyhexyl) terephthalate (MEHHTP), a hydroxyl metabolite of the phthalate alternative Di-2-ethylhexyl terephthalate (DEHTP), is a liver X receptor α (LXRα) agonist with a binding energy of -7.41 kcal/mol. Mono (2-ethyl-5-hydroxyhexyl) terephthalate upregulates LXRα downstream targets such as SREBP-1c and FASN and increases lipogenic enzyme activity in hepatocytes, and elevating triglyceride (TG) levels. Mono (2-ethyl-5-hydroxyhexyl) terephthalate is promising for research of nonalcoholic fatty liver disease (NAFLD) .
loading...
    loading...
Cat. No.: HY-139067
CAS No.: 56845-83-1
Target:  

LXR

Research Areas:  

Cardiovascular Disease

25(S)-27-Hydroxy cholesterol is a metabolite of CYP27A1 mediated cholesterol hydroxylation. 25(S)-27-Hydroxy cholesterol inhibits melanoma cell proliferation .
loading...
    loading...